Warning: This security is no longer trading.
Sanofi completes acquisition of Synthorx, Inc.
Synthorx, Inc. (THOR): Price and Financial Metrics
THOR Price/Volume Stats
Current price | $67.99 | 52-week high | $71.90 |
Prev. close | $67.99 | 52-week low | $11.05 |
Day low | $67.99 | Volume | 698,100 |
Day high | $68.01 | Avg. volume | 474,507 |
50-day MA | $48.43 | Dividend yield | N/A |
200-day MA | $23.82 | Market Cap | 2.20B |
THOR Stock Price Chart Interactive Chart >
Synthorx, Inc. (THOR) Company Bio
Synthorx, Inc. is a biopharmaceutical company, which focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA.
THOR Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | 284.34% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | 0.00% |
2019 | 302.13% |
Loading social stream, please wait...